Paolo Ghia
Professor from IRCCS Ospedale San Raffaele in Milano, Italy. Director of the CLL strategic program.
Top 3 podcasts with Paolo Ghia
Ranked by the Snipd community
May 3, 2025 • 59min
Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances
Dr. Jennifer R Brown, a leader in CLL research at Dana-Farber, and Prof. Paolo Ghia from Milan, dive into the latest breakthroughs in chronic lymphocytic leukemia. They explore the role of new therapies like BTK inhibitors, comparing their effectiveness with traditional treatments. The conversation highlights the significance of monitoring minimal residual disease and discusses recent findings on treatment risks like hypertension. They also touch on innovative strategies emerged during the COVID-19 pandemic, paving the way for future advancements in CLL care.
Mar 22, 2024 • 10min
Monoclonal B-cell lymphocytosis: classification, biology and exploring the possibility of early interception
Experts Stephen Ansell, Paolo Ghia, and Andrew Rawstron discuss Monoclonal B-cell lymphocytosis (MBL) as a precursor to CLL, exploring biology, classification, and early interception possibilities. They cover MBL progression, genetic similarities with CLL, B-cell receptor as an early marker, and the importance of immune system interactions for early intervention.
Jul 27, 2021 • 37min
The CLL Sessions: highlights from EHA and ICML 2021
Experts Paolo Ghia, Susan O'Brien, Lydia Scarfò, and Othman Al-Sawaf review exciting updates in chronic lymphocytic leukemia (CLL) from EHA and ICML 2021. They discuss key clinical trials, second-generation BTKs, fixed-duration therapy, depth of response, stopping treatment, retreatment potential, progression-free survival, VTK inhibitors, akylobrutinib vs. britinib, and different CLL treatment regimens.
